A Randomized Trial of Concurrent Smoking-Cessation and Substance Use Disorder Treatment in Stimulant-Dependent Smokers

Clicks: 166
ID: 272419
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #101 of 273 articles by views in the journal of clinical psychiatry

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 273 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Article Abstract Objective: To evaluate the impact of concurrent treatments for substance use disorder and nicotine-dependence for stimulant-dependent patients. Method: A randomized, 10-week trial with follow-up at 3 and 6 months after smoking quit date conducted at 12 substance use disorder treatment programs between February 2010 and July 2012. Adults meeting DSM-IV-TR criteria for cocaine and/or methamphetamine dependence and interested in quitting smoking were randomized to treatment as usual (n = 271) or treatment as usual with smoking-cessation treatment (n = 267). All participants received treatment as usual for substance use disorder treatment. Participants assigned to treatment as usual with concurrent smoking-cessation treatment received weekly individual smoking cessation counseling and extended-release bupropion (300 mg/d) during weeks 1-10. During post-quit treatment (weeks 4-10), participants assigned to treatment as usual with smoking-cessation treatment received a nicotine inhaler and contingency management for smoking abstinence. Weekly proportion of stimulant-abstinent participants during the treatment phase, as assessed by urine drug screens and self-report, was the primary outcome. Secondary measures included other substance/nicotine use outcomes and treatment attendance. Results: There were no significant treatment effects on stimulant-use outcomes, as measured by the primary outcome and stimulant-free days, on drug-abstinence, or on attendance. Participants assigned to treatment as usual with smoking-cessation treatment, relative to those assigned to treatment as usual, had significantly better outcomes for drug-free days at 6-month follow-up (χ21 = 4.09, P < .05), with a decrease in drug-free days from baseline of −1.3% in treatment as usual with smoking-cessation treatment and of −7.6% in treatment as usual. Participants receiving treatment as usual with smoking-cessation treatment, relative to those receiving treatment as usual, had significantly better outcomes on smoking point-prevalence abstinence (25.5% vs 2.2%; χ21 = 44.69, P < .001; OR = 18.2). Conclusions: These results suggest that providing smoking-cessation treatment to illicit stimulant-dependent patients in outpatient substance use disorder treatment will not worsen, and may enhance, abstinence from nonnicotine substance use. Trial Registration: ClinicalTrials.gov identifier: NCT01077024 J Clin Psychiatry © Copyright 2013 Physicians Postgraduate Press, Inc. Submitted: March 1, 2013; accepted July 15, 2013. Online ahead of print: December 10, 2013 (doi:10.4088/JCP.13m08449). Corresponding author: Theresa M. Winhusen, PhD, University of Cincinnati, 3210 Jefferson Ave, Cincinnati, OH 45220 (winhusen@carc.uc.edu).
Reference Key
winhusen2013thea Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Theresa M. Winhusen;Gregory S. Brigham;Frankie Kropp;Robert Lindblad;John G. Gardin II;Pat Penn;Candace Hodgkins;Thomas M. Kelly;Antoine Douaihy;Michael McCann;Lee D. Love;Eliot DeGravelles;Ken Bachrach;Susan C. Sonne;Bob Hiott;Louise Haynes;Gaurav Sharma;Daniel F. Lewis;Paul VanVeldhuisen;Jeff Theobald;Udi Ghitza;
Journal the journal of clinical psychiatry
Year 2013
DOI
DOI not found
URL
https://www.psychiatrist.com/jcp/addiction/substance-use-disorders/randomized-trial-concurrent-smoking-cessation-substance/
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.